John Meadows
Allergy · Birmingham, ALNPI 1811952849
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $143,250 of the $203,503 with a category attached, or 70.4%. 30 manufacturers reported payments, led by AstraZeneca at 26.6% of the total. Reporting peaked in 2022 at $62,748 and has fallen 98.7% since, to $838 in 2025.
Across 577 payments — averaging $352.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$54K
- Teva Pharmaceuticals USA, Inc.$51K
- Regeneron Healthcare Solutions, Inc.$23K
- Sanofi$20K
- Pfizer$20K
- Takeda Pharmaceuticals U.S.A., Inc.$17K
- plus $18K from 24 others
What the payments were for
- Consulting fees$36,01918%
- Speaking & faculty fees$143,25070%
- Grants$5000%
- Travel & lodging$11,9186%
- Food & beverage$11,6866%
- Education$1300%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 124 | $54,061 |
| Teva Pharmaceuticals USA, Inc. | 92 | $51,495 |
| Regeneron Healthcare Solutions, Inc. | 60 | $23,421 |
| Sanofi | 45 | $20,277 |
| Pfizer | 39 | $19,530 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $16,771 |
| Merck | 11 | $7,212 |
| Optinose US, Inc. | 5 | $5,000 |
| Novartis | 12 | $2,407 |
| GSK | 107 | $1,072 |
| Alk-abello, Inc | 4 | $552 |
| Regeneron | 5 | $416 |
| Grifols USA, LLC | 11 | $203 |
| Kaleo, Inc. | 10 | $189 |
| CSL Behring | 6 | $137 |
| Boehringer Ingelheim | 8 | $126 |
| Genentech USA, Inc. | 3 | $122 |
| Greer Laboratories, Inc. | 4 | $111 |
| Biocryst US Sales Co., LLC | 1 | $74 |
| Eyevance Pharmaceuticals LLC | 3 | $52 |
| Lilly USA, LLC | 2 | $48 |
| Amgen | 3 | $45 |
| Sanofi-aventis U.S. LLC | 1 | $31 |
| LEO Pharma Inc. | 2 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $27 |
| USWM, LLC | 1 | $25 |
| Ionis Pharmaceuticals, Inc. | 1 | $25 |
| Melinta Therapeutics, LLC | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $15 |
| Glaukos Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DUPIXENT$43,788
- TEZSPIRE$35,243
- ProAir Digihaler$32,505
- AirDuo RespiClick$30,894
- ArmonAir Digihaler$27,393
- FASENRA$16,428
- EUCRISA$11,349
- AirDuo Digihaler$8,554
- CIBINQO$7,050
- Xhance$5,000
- GLASSIA$1,600
- BREZTRI$304
- SYMBICORT$165
- CINRYZE$125
- Odactra$117
- Ragwitek$117
- Grastek$117
How this compares
Too few allergy providers in Alabamato place this figure against a meaningful peer group, so we don't.
Other allergy in Birmingham
- John ToleBirmingham$33K
- William FancherBirmingham$3K
- Joseph GiannobileBirmingham$991
- Druhan HowellMobile$201K
- Shashi KumarHuntsville$8K
- Lucinda PattonMobile$3K
- Valerie leMadison$1K
- Charles BrentnallSylacauga$1K
- Steven HelmTuscaloosa$185
- Alma HerreraMobile$19
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.